COVID‐19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin

BioFactorsVolume 46, Issue 3 p. 306-308 HYPOTHESIS COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin Theoharis C. Theoharides, Corresponding Author Theoharis C. Theoharides [email protected] orcid.org/0000-0002-1598-460X Laboratory of Molecular Immunopharmacology and Drug Discovery, Department of Immunology, Tufts University School of Medicine, Boston, MA School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts Department of Internal Medicine, Tufts University School of Medicine and Tufts Medical Center, Boston, Massachusetts Correspondence Theoharis C. Theoharides, Department of Immunology, Tufts University School of Medicine, 136 Harrison Avenue, Suite 304, Boston, MA 02111. Email: [email protected]Search for more papers by this author Theoharis C. Theoharides, Corresponding Author Theoharis C. Theoharides [email protected] orcid.org/0000-0002-1598-460X Laboratory of Molecular Immunopharmacology and Drug Discovery, Department of Immunology, Tufts University School of Medicine, Boston, MA School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts Department of Internal Medicine, Tufts University School of Medicine and Tufts Medical Center, Boston, Massachusetts Correspondence Theoharis C. Theoharides, Department of Immunology, Tufts University School of Medicine, 136 Harrison Avenue, Suite 304, Boston, MA 02111. Email: [email protected]Search for more papers by this author First published: 27 April 2020 https://doi.org/10.1002/biof.1633Citations: 115